Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Business Insights | The Gastrointestinal Market Outlook to 2012

The Gastrointestinal Market Outlook to 2012

As the GIT Market begins to feature increasingly high levels of generic competition, the focus of pharmaceutical R&D strategies has shifted towards new therapy areas such as Crohn’s disease and Irritable Bowel Syndrome (IBS). Although such shifts are becoming the driving force for market transformation, growth rates may remain low due to the increased availability of effective generic medicines and fewer launches of innovative new drugs. ‘The Gastrointestinal Market Outlook to 2012’ is a new report published by Business Insights that provides a detailed epidemiological analysis of key indications within major GIT markets, and examines the factors impacting their prevalence. The dynamics of the market are examined through an analysis of leading brands within each indication and a profile of the pharma companies and market trends influencing the sales of GIT treatments. Forecasts for major product sales over the 2006-12 period are also provided.

About the Author: Melissa Zebrowski

Melissa Zebrowski is a pharmaceutical industry analyst with over seven years’ of experience in healthcare and biopharma policy. During this time she has worked for four years as a consultant providing market research and analysis services, with a therapeutic focus spanning Oncology, Central Nervous System, Gastrointestinal, and

Infectious Disease areas.

Published: October 2007 - Global.
Table of Contents
Table of Contents (PDF)
Price: $2,875.00 / €1,921.65

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions